Return to search results.
Complete title: Phase 2 Study of SPI-1620 in Combination with Docetaxel as a Second-Line Treatment for Patients with Advanced Biliary Cancer
|Research Study Number||20131451|
|Principal Investigator||Gabriela Chiorean|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Bile Duct Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.